久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

AstraZeneca to build $200m center in China

Updated: 2011-10-12 09:56

By Ma Zhenhuan (China Daily)

  Comments() Print Mail Large Medium  Small 分享按鈕 0

AstraZeneca to build $200m center in China

AstraZeneca PLC workers load blister strips onto a packing line at a factory in Macclesfield, United Kingdom. The UK-based medical company will create 600 jobs by building a new factory in Taizhou, Jiangsu province. [Photo / Bloomberg]

SHANGHAI - AstraZeneca PLC, one of the world's leading pharmaceutical companies, said it would invest $200 million to launch a new manufacturing facility in China to meet growing demand, including in rural areas.

Construction work on the project, in the China Medical City in Taizhou of East China's Jiangsu province, is scheduled for completion by the end of 2013, creating approximately 600 jobs.

This will be London-based AstraZeneca's largest single investment in a manufacturing facility globally. The new plant will produce intravenous and oral solid products, the company said.

"The new facility will significantly enhance our capacity and allow us to meet the growing healthcare demand of the Chinese population, and help us expand into the 900 million (rural) people outside of the big cities and hospitals," Mark Mallon, president of AstraZeneca China, told China Daily in an exclusive interview on Monday.

"It will also allow us to free up some capacity at our existing manufacturing facility in Wuxi, Jiangsu, to bring on more new innovative products that will be launched over the next few years," he added.

The Chinese pharmaceutical market grew from $10 billion in 2004 to $41 billion in 2010, according to market research agency IMS Health Inc, and it is expected to reach $102 billion by 2015.

Mallon said that he believes the Chinese government's focus on healthcare reform and investment in improving healthcare infrastructure and expanding insurance coverage will continue to drive the company's business growth and increase access to quality medicines over the longer term.

AstraZeneca will launch two new products, Faslodex, a treatment for breast cancer, and Onglyza, a new treatment for Type-2 Diabetes, in China this year.

Mallon also mentioned that the company is planning to launch Brilinta, an oral antiplatelet treatment for acute coronary syndrome, next year in China.

With an enhanced manufacturing capacity and the launch of more innovative new medicines, the company is planning to produce more affordable medicines for Chinese patients. It will adopt a multi-channel approach to sell its products to markets beyond big cities and hospitals.

Aside from the medical sales representatives who deal with individual physicians in big cities, the company has developed a team of about 100 customer service representatives who organize educational programs for small clinics and community health centers in China's rural areas.

It will also set up an inbound and outbound call center to reach out to healthcare professionals through phone calls, helping them learn more about AstraZeneca products, he said.

The company, which entered China in 1993, has invested about $500 million in the country, including an innovation center in Zhangjiang, Shanghai.

主站蜘蛛池模板: 国产欧美在线观看不卡一 | 日韩在线视频中文字幕 | 国产精品亚洲精品一区二区三区 | 国产欧美日本在线观看 | 中文字幕咪咪网 | 在线日本看片免费人成视久网 | 撸久久 | 国产成人综合日韩精品婷婷九月 | 日本精品夜色视频一区二区 | 一级毛片播放 | 快色网站 | 99久久国产综合精品五月天 | 国产成人丝袜网站在线观看 | 精品国产免费第一区二区三区日韩 | 欧美日本道免费一区二区三区 | 成人国产欧美精品一区二区 | 免费看成人频视在线视频 | 四色6677最新永久网站 | 国产亚洲精品久久久久久午夜 | 久久精品免观看国产成人 | 久久亚洲精品中文字幕 | 免费看欧美一级特黄a大片一 | 狠狠色丁香九九婷婷综合五月 | 黄色免费看片网站 | 亚洲精品欧洲久久婷婷99 | 最新国产午夜精品视频不卡 | 一区二区三区四区免费视频 | 国产亚洲欧美日韩在线观看一区二区 | 欧美精品xx | 国产精品免费视频能看 | 国产亚洲精品午夜高清影院 | 日本免费人做人一区在线观看 | 黄影| 在线观看欧美亚洲日本专区 | 国产麻豆福利a v在线播放 | 99在线观看精品 | 国内精品小视频 | 国产精品福利午夜h视频 | 毛片亚洲毛片亚洲毛片 | 中文字幕在线视频观看 | 99视频免费在线 |